Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults

医学 阿莫西林 鼻窦炎 倾向得分匹配 不利影响 队列 回顾性队列研究 急诊科 队列研究 内科学 并发症 抗生素 儿科 急诊医学 抗菌剂 外科 门诊护理 重症监护医学 阿莫西林/克拉维酸 头孢呋辛
作者
Timothy J. Savage,Anne M. Butler,Matthew P. Kronman,Michael J. Durkin,Sushama Kattinakere Sreedhara,Sarah Kabbani,Lauri A. Hicks,Krista F. Huybrechts
出处
期刊:JAMA [American Medical Association]
标识
DOI:10.1001/jama.2025.26902
摘要

Importance: Acute sinusitis has the highest rate of antibiotic prescribing in adults younger than 65 years. There is no consensus regarding whether amoxicillin-clavulanate or amoxicillin should be first-line treatment for uncomplicated acute sinusitis in adults. Objective: To compare the risk of treatment failure and adverse events between standard-dose amoxicillin-clavulanate vs standard-dose amoxicillin for acute sinusitis in adults. Design, Setting, and Participants: New-user, active comparator retrospective cohort study using a nationwide health care utilization database comparing amoxicillin-clavulanate vs amoxicillin for adults aged 18 to 64 years with outpatient acute sinusitis. Patients with a new acute sinusitis diagnosis between January 1, 2018, and December 1, 2023, were eligible. Statistical analysis was conducted between July and November 2025. Propensity score matching was used to help mitigate confounding. Exposures: Standard-dose amoxicillin-clavulanate (875 mg-125 mg twice daily) or standard-dose amoxicillin (875 mg twice daily or 500 mg 3 times daily). Main Outcomes and Measures: The primary outcome was treatment failure, defined as the first occurrence of a new antibiotic dispensation (with or without an outpatient visit), emergency department or inpatient encounter for acute sinusitis, or inpatient encounter for a sinusitis complication assessed 1 to 14 days after treatment initiation. Antibiotic-associated adverse events and secondary infections were also assessed. Results: The full cohort included 521 244 eligible patients. After propensity score matching, there were 234 608 patients (117 304 patients per group; 65.5% female; median [IQR] age, 43 [31-54] years). Treatment failure occurred in 3.1% of patients overall, with 0.03% requiring an emergency department or inpatient encounter. There was no observed difference in the risk of treatment failure between the amoxicillin-clavulanate vs amoxicillin groups (3.0% vs 3.1%; risk ratio [RR], 0.96 [95% CI, 0.92-1.01]), which was consistent across sensitivity analyses. There was no difference in antibiotic-associated adverse events (1.3% vs 1.2%; RR, 1.04 [95% CI, 0.97-1.12]). The risk of secondary infections was higher for amoxicillin-clavulanate vs amoxicillin, including yeast infections (1.1% vs 0.8%; RR, 1.40 [95% CI, 1.29-1.53]) and Clostridioides difficile infections (0.04% vs 0.02%; RR, 2.14 [95% CI, 1.29-3.54]). Conclusions and Relevance: In this observational study of patients aged 18 to 64 years with acute sinusitis treated in the outpatient setting with standard-dose amoxicillin-clavulanate or standard-dose amoxicillin, there was no observed difference in treatment failure. Amoxicillin-clavulanate was associated with a higher, albeit rare, risk of adverse events. These findings suggest standard-dose amoxicillin may be a preferred first-line treatment for adults with uncomplicated acute sinusitis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ashore完成签到,获得积分10
1秒前
2秒前
慢慢完成签到 ,获得积分10
2秒前
琪qi完成签到,获得积分10
3秒前
RATHER发布了新的文献求助10
4秒前
彭于晏的应助被幸运的成仁采纳,获得10
4秒前
劳小呆发布了新的文献求助10
4秒前
Tengfei753951完成签到 ,获得积分10
4秒前
子岚发布了新的文献求助10
4秒前
5秒前
超级无敌的应助被强健的篮球采纳,获得10
5秒前
东都行发布了新的文献求助10
5秒前
6秒前
6秒前
6秒前
6秒前
7秒前
吃西瓜不吐籽完成签到 ,获得积分10
8秒前
elysia发布了新的文献求助10
8秒前
8秒前
六月雪发布了新的文献求助10
9秒前
所所的应助被lzh采纳,获得10
9秒前
林正心完成签到,获得积分10
10秒前
奇思妙想安德鲁完成签到,获得积分10
11秒前
顾矜的应助被热情的乐荷采纳,获得10
12秒前
9202211125完成签到,获得积分10
12秒前
郭夹心发布了新的文献求助10
12秒前
Akim的应助被一期一会采纳,获得10
12秒前
hmh发布了新的文献求助15
12秒前
水煮电吹风的应助被00hello00采纳,获得10
12秒前
13秒前
drfwjuikesv发布了新的文献求助10
13秒前
14秒前
一米阳光发布了新的文献求助10
14秒前
香蕉觅云的应助被Besttin9799采纳,获得30
14秒前
刘白完成签到,获得积分10
14秒前
Tracy发布了新的文献求助10
14秒前
LIUDAN发布了新的文献求助10
15秒前
16秒前
dieeee完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183667
求助须知:如何正确求助?哪些是违规求助? 9572953
关于积分的说明 21828185
捐赠科研通 7780853
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558251
邀请新用户注册赠送积分活动 2480500